Inhibition of PARP by PARPi attenuates alkylating DNA damage-induced EZH2 downregulation, thereby promotes EZH2-mediated gene silencing and cancer stem cell property compared with PARPi-untreated cells [33]. This evidence concerns the gene EZH2 and cancer.